Progressnotes - October/November 2012
- About MUSC Health
In June 2002, Thomas E. Keane, MBBCh, a surgical urologic oncologist and nationally recognized researcher with previous appointments at Emory University and Grady Memorial Hospital in Atlanta, accepted the position of Chair of the Department of Urology at MUSC, where he holds the Brockmann Chair in Urologic Oncology.
Since assuming leadership of the department, he has expanded the faculty from four to twelve surgeons and the residency from one resident per year to three (for a total of 15) and has established two fellowships, one in minimally invasive genitourinary (GU) oncology and a second in bladder and pelvic health. The Department of Urology has obtained its first endowed chair under his guidance, and a second chair is currently under development.
An avid researcher, he has served as principal investigator/co-investigator on more than 20 major clinical/preclinical studies. His work focuses on innovative concepts in translational research, including using human tumor xenografts to investigate new therapies as they relate to GU malignancies with particular reference to cytotoxic agents, sphingolipids, and boron-containing compounds. He holds a number of U.S. patents.
Dr. Keane was recently appointed Editor-in-Chief of Urology Today. He has published more than 100 articles in such peer-reviewed journals as the Journal of Urology, the Journal of Clinical Investigation, and Cancer Research. He provides editorial services to numerous urology journals and is coeditor of the text Glenn’s Urologic Surgery. Dr. Keane has chaired the renal section of the Eastern Cooperative Oncology Group and is an accomplished speaker, having delivered many presentations to professional societies and symposia throughout the U.S. and abroad.
Dr. Keane obtained his medical degree in Ireland and completed seven years of general surgery before obtaining a research fellowship at Duke University, which led to a urologic residency.